{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:01Z","timestamp":1740144121166,"version":"3.37.3"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rotunda Foundation","award":["RF\/RCSI\/2020\/04"],"award-info":[{"award-number":["RF\/RCSI\/2020\/04"]}]},{"name":"Medicem Technology S.R.O"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Induction of labour (IOL) at 39 weeks has been shown to decrease maternal and neonatal adverse outcomes. Given the growing demand for 39-week IOL, it is imperative that effective methods be assessed for induction in the outpatient setting.<\/jats:p>\n                <jats:p>The aim of this study is to answer the clinical question as to whether Dilapan-S\u00ae vs Propess\u00ae as a method of cervical ripening is non-inferior in the outpatient setting at 39 weeks and to ascertain whether Dilapan-S\u00ae 12 h is non-inferior to Dilapan-S\u00ae 24 h.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study is an open-label parallel group single-centre <jats:italic>randomised<\/jats:italic> trial.<\/jats:p>\n                <jats:p>Participants are normal risk nulliparous women who have no pregnancy-related or medical contraindication to IOL. Women will be randomised to one of three induction groups\u2014Dilapan-S\u00ae (12-h insertion or 24-h insertion) or Propess. Induction will be initiated between 39+0 and 39+4 weeks\u2019 gestation and participants will return home for either 12 or 24 h. They will be readmitted 12\/24 h later in order to continue with induction of labour.<\/jats:p>\n                <jats:p>Patient recruitment will take place over 30 months within a single centre. The study will recruit a maximum 109 women for each study arm. Total duration of participants\u2019 involvement in the trial will be 8 weeks to allow for postpartum follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will definitively answer whether Dilapan-S is non-inferior to Propess\u00ae as a method of induction of labour in the outpatient setting and whether cervical ripening with Dilapan-S over a 12-h timeframe is non-inferior to cervical ripening with Dilapan-S over a 24-h timeframe.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>EudraCT Number 2019-004697-25 Registered 14 September 2020<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07174-7","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T02:02:42Z","timestamp":1677117762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A randomised open-label trial to assess outpatient induction of labour (HOMEIND) and compare efficacy of Propess vs Dilapan-S\u00ae for induction of labour at 39 weeks\u2019 gestation in normal risk nulliparous women: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-262X","authenticated-orcid":false,"given":"Sarah M.","family":"Nicholson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orla","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zara","family":"Molphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergal","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"issue":"23","key":"7174_CR1","first-page":"2278","volume":"379","author":"WA Grobman","year":"2018","unstructured":"Grobman WA. Labor induction vs. expectant management of low-risk pregnancy. N Engl J Med. 2018;379(23):2278\u20139.","journal-title":"N Engl J Med."},{"issue":"4","key":"7174_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ajog.2019.02.046","volume":"221","author":"WA Grobman","year":"2019","unstructured":"Grobman WA, Caughey AB. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies. Am J Obstetr Gynecol. 2019;221(4):304\u201310.","journal-title":"Am J Obstetr Gynecol"},{"issue":"1","key":"7174_CR3","doi-asserted-by":"publisher","first-page":"103 e1","DOI":"10.1016\/j.ajog.2014.06.054","volume":"212","author":"JL Bailit","year":"2015","unstructured":"Bailit JL, Grobman W, Zhao Y, Wapner RJ, Reddy UM, Varner MW, et al. Nonmedically indicated induction vs expectant treatment in term nulliparous women. Am J Obstet Gynecol. 2015;212(1):103 e1\u20137.","journal-title":"Am J Obstet Gynecol."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07174-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T02:07:32Z","timestamp":1677118052000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07174-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":3,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7174"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07174-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the National Maternity Hospital Ethics Committee 22 September 2020, Dublin, Ireland.Approved by the Rotunda Hospital Ethics Committee 23 November 2020.HPRA approval granted 20 November 2020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Whilst there is no individual data published, the participant information materials specifies the use of data for research purposes and specifies that the data will be used to produce academic papers\/presentations. The participant information materials and informed consent form are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"An educational grant was provided to the research department from Medicem Technology S.R.O. The trial has been peer-reviewed by the funding bodies. Neither funder had a role in trial design. The funder will have no role in the data collection, data analysis, data interpretation, report writing, or the decision to submit the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"135"}}